FLT - PET imaging does not always “ light up ” proliferating tumor cells
نویسندگان
چکیده
[F]FLT-PET imaging does not always “light up” proliferating tumor cells Cathy C. Zhang, Zhengming Yan, Wenlin Li, Kyle Kuszpit, Cory L Painter, Qin Zhang, Patrick B Lappin, Tim Nichols, Maruja E Lira, Timothy Affolter, Neeta R. Fahey, Carleen Cullinane, Mary Spilker, Kenneth Zasadny Peter O'Brien, Dana Buckman, Anthony Wong and James G. Christensen Authors' Affiliation: Oncology Research Unit, Pharmacokinetics, Dynamics & Metabolism, Bio-Imaging Unit, Drug Safety Research & Development, Molecular Medicine, Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California and 2, Groton Laboratories, Groton, Connecticut, USA . Centre for Molecular Imaging and Translational Research Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Australia Requests for reprints: Cathy C. Zhang, Oncology Research Unit, Pfizer Global Research and Development, 10724 Science Center Rd., San Diego, CA 92121. Phone: 858-622-3125; Fax: 858-622-5999; E-mail: [email protected]
منابع مشابه
[F]FLT–PET Imaging Does Not Always "Light Up" Proliferating Tumor Cells
Purpose: [F]FLT (30-Fluoro-30 deoxythymidine)–PET imaging was proposed as a tool for measuring in vivo tumor cell proliferation. The aim of this article was to validate the use of [F]FLT–PET imaging for measuring xenograft proliferation and subsequent monitoring of targeted therapy. Experimental Design: In exponentially growing xenografts, factors that could impact the outcome of [F]FLT–PET ima...
متن کامل[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cells.
PURPOSE [(18)F]FLT (3'-Fluoro-3' deoxythymidine)-PET imaging was proposed as a tool for measuring in vivo tumor cell proliferation. The aim of this article was to validate the use of [(18)F]FLT-PET imaging for measuring xenograft proliferation and subsequent monitoring of targeted therapy. EXPERIMENTAL DESIGN In exponentially growing xenografts, factors that could impact the outcome of [(18)F...
متن کامل18F-Fluorothymidine-Pet Imaging of Glioblastoma Multiforme: Effects of Radiation Therapy on Radiotracer Uptake and Molecular Biomarker Patterns
Introduction. PET imaging is a useful clinical tool for studying tumor progression and treatment effects. Conventional (18)F-FDG-PET imaging is of limited usefulness for imaging Glioblastoma Multiforme (GBM) due to high levels of glucose uptake by normal brain and the resultant signal-to-noise intensity. (18)F-Fluorothymidine (FLT) in contrast has shown promise for imaging GBM, as thymidine is ...
متن کاملLimits of [18F]-FLT PET as a Biomarker of Proliferation in Oncology
BACKGROUND Non-invasive imaging biomarkers of cellular proliferation hold great promise for quantifying response to personalized medicine in oncology. An emerging approach to assess tumor proliferation utilizes the positron emission tomography (PET) tracer 3'-deoxy-3'[(18)F]-fluorothymidine, [(18)F]-FLT. Though several studies have associated serial changes in [(18)F]-FLT-PET with elements of t...
متن کامل18F-Fluorothymidine PET-CT for Resected Malignant Gliomas before Radiotherapy: Tumor Extent according to Proliferative Activity Compared with MRI
OBJECTIVE To compare the presence of post-operative residual disease by magnetic resonance imaging (MRI) and [18F]fluorothymidine (FLT)-positron emission tomography (PET)-computer tomography (CT) in patients with malignant glioma and to estimate the impact of 18F-FLT PET on the delineation of post-operative target volumes for radiotherapy (RT) planning. METHODS Nineteen patients with post-ope...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2011